Soluble Fms-like tyrosine cinase 1 (sFLt-1) and antibody against AT1-receptor in preclempsia a comparison in a blind study design
Hlavní autoři: | Verlohren, S, Herse, F, Wenzel, K, Redman, C, Dudennhausen, J, Dechend, R |
---|---|
Médium: | Journal article |
Vydáno: |
2008
|
Podobné jednotky
-
Soluble Fms-Like Tyrosine Kinase-1 (Sflt-1) and Autoantibodies Against the AT1-Receptor in Preeclampsia in a Matched Pair, Blinded, Study Design.
Autor: Verlohren, S, a další
Vydáno: (2008) -
Prevalence of agonistic autoantibodies against the angiotensin II type 1 receptor and soluble fms-like tyrosine kinase 1 in a gestational age-matched case study.
Autor: Herse, F, a další
Vydáno: (2009) -
Increased placental sFlt-1 but unchanged PlGF expression in late-onset preeclampsia
Autor: Laura Ehrlich, a další
Vydáno: (2017-04-01) -
Resveratrol inhibits release of soluble fms-like tyrosine kinase (sFlt-1) and soluble endoglin and improves vascular dysfunction – implications as a preeclampsia treatment
Autor: Natalie J. Hannan, a další
Vydáno: (2017-05-01) -
Altered Level of Soluble fms-like Tyrosine Kinase 1 (sFlt1) and Hypoxia Inducible Factor-1alpha (HIF-1alpha) in Normotensive Pregnancy and Preeclampsia
Autor: John Wantania, a další
Vydáno: (2013-08-01)